# The X Factor in Immunity: Sex Differences Shaped by the X Chromosome

**Authors:** Katherine B. Radovanovic, Megan Wynalda, Montserrat C. Anguera

PMC · DOI: 10.1111/imr.70107 · Immunological Reviews · 2026-01-23

## TL;DR

This paper explores how sex differences in immunity are influenced by the X chromosome and sex hormones, aiming to improve sex-specific treatments for immune-related diseases.

## Contribution

The paper highlights recent insights into X-linked gene regulation and sex hormone effects on immune responses, offering new perspectives for sex-specific therapies.

## Key findings

- Females show stronger immune responses than males due to sex hormones and X chromosome differences.
- X-Chromosome Inactivation (XCI) and selective gene reactivation on the Xi influence immune cell function in females.
- Dosage-sensitive X-linked genes contribute to female-biased autoimmune diseases and immune signaling differences.

## Abstract

There are sex differences with immune responses where females exhibit stronger immune responses compared to males. Both sex hormones and sex chromosome differences between males and females contribute to the observed sex differences with innate and adaptive immune cell composition and function. Here, we present recent findings investigating sex differences with immune cells and responses, highlighting contributions from sex hormones or X‐linked genes. We also review the epigenetic gene regulatory mechanisms that form the inactive X chromosome (Xi), known as X‐Chromosome Inactivation (XCI), the heterochromatic nature of the Xi that allows for selective gene reactivation, and recent work investigating the mechanisms of XCI maintenance in female immune cells. We also highlight some dosage‐sensitive X‐linked genes involved in female‐biased autoimmune disease, discuss sex differences with immune signaling pathways, and sex differences with viral infections and vaccine responses with the ultimate goal to leverage these insights for the development of sex‐specific therapeutic interventions for immune‐related diseases.

## Linked entities

- **Diseases:** autoimmune disease (MONDO:0007179)

## Full-text entities

- **Genes:** SETDB1 (SET domain bifurcated histone lysine methyltransferase 1) [NCBI Gene 9869] {aka ESET, H3-K9-HMTase4, KG1T, KMT1E, TDRD21}, Nelfcd (negative elongation factor complex member C/D, Th1l) [NCBI Gene 57314] {aka 2410003I03Rik, NELF-D, Th1, Th1l}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454] {aka AVP, CRF2-1, IFN-R-1, IFN-alpha-REC, IFNAR, IFNBR}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Nanog (Nanog homeobox) [NCBI Gene 71950] {aka 2410002E02Rik, ENK, Stm1, ecat4}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, BTK (Bruton tyrosine kinase) [NCBI Gene 695] {aka AGMX1, AT, ATK, BPK, IGHD3, IMD1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, Ikbkb (inhibitor of kappaB kinase beta) [NCBI Gene 16150] {aka IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, Tlr13 (toll-like receptor 13) [NCBI Gene 279572] {aka Gm713}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, F2RL1 (F2R like trypsin receptor 1) [NCBI Gene 2150] {aka GPR11, PAR2}, Cxcr3 (C-X-C motif chemokine receptor 3) [NCBI Gene 12766] {aka Cd183, Cmkar3}, CR2 (complement C3d receptor 2) [NCBI Gene 1380] {aka C3DR, CD21, CR, CVID7, SLEB9}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, TLR8 (toll like receptor 8) [NCBI Gene 51311] {aka CD288, IMD98, TLR-8, hTLR8}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113] {aka PRSS10}, Prc1 (protein regulator of cytokinesis 1) [NCBI Gene 233406] {aka D7Ertd348e}, TSIX (TSIX transcript, XIST antisense RNA) [NCBI Gene 9383] {aka LINC00013, NCRNA00013, XIST-AS, XIST-AS1, XISTAS}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, JAK3 (Janus kinase 3) [NCBI Gene 3718] {aka JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, JAK1 (Janus kinase 1) [NCBI Gene 3716] {aka AIIDE, JAK1A, JAK1B, JTK3}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, LYN (LYN proto-oncogene, Src family tyrosine kinase) [NCBI Gene 4067] {aka JTK8, SAIDV, p53Lyn, p56Lyn}, PF4 (platelet factor 4) [NCBI Gene 5196] {aka CXCL4, PF-4, SCYB4}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, IFNK (interferon kappa) [NCBI Gene 56832] {aka IFNT1, INFE1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, CD14 (CD14 molecule) [NCBI Gene 929], CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, IFN1@ (interferon, type 1, cluster) [NCBI Gene 3438] {aka IFNA}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, Cfp (complement factor properdin) [NCBI Gene 18636] {aka BCFG, Pfc}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, Ftx (Ftx transcript, Xist regulator, non-protein coding) [NCBI Gene 78878] {aka B230206F22Rik, NCRNA00182, Thcytx}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Ar (androgen receptor) [NCBI Gene 11835] {aka Tfm}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IFNA2 (interferon alpha 2) [NCBI Gene 3440] {aka IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A}, Fcer1g (Fc receptor, IgE, high affinity I, gamma polypeptide) [NCBI Gene 14127] {aka CD23, FcR-gamma, FcR[g], FcRgamma, Fce1g, FcepsilonRI}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** multiple sclerosis (MESH:D009103), CAD (MESH:D003324), Long COVID (MESH:D000094024), glomerulonephritis (MESH:D005921), lung pathologies (MESH:D008171), ovarian dysgenesis (OMIM:233300), Sjogren's syndrome (MESH:D012859), impaired intellectual development (MESH:D008607), dermatomyositis (MESH:D003882), hypothermia (MESH:D007035), chronic inflammation (MESH:D007249), rheumatic diseases (MESH:D012216), pathologies (MESH:D005598), type 1 diabetes (MESH:D003922), B cell tumor (MESH:D015448), Influenza (MESH:D007251), chronic (MESH:D002908), viral infection (MESH:D014777), atherosclerosis (MESH:D050197), brain fog (MESH:D005222), COVID-19 (MESH:D000086382), joints (MESH:D007592), lupus nephritis (MESH:D008181), injuries (MESH:D014947), myeloproliferative disorders (MESH:D009196), death (MESH:D003643), cardiovascular pathologies (MESH:D002318), AIDS (MESH:D000163), asbestos (MESH:D001195), immune diseases (MESH:D007154), RA (MESH:D001172), thrombocytopenia (MESH:D013921), HIV (MESH:D015658), short stature (MESH:D006130), fatigue (MESH:D005221), Y-linked autoimmune accelerating (MESH:D050174), fibrosis (MESH:D005355), sepsis (MESH:D018805), cancer (MESH:D009369), ulcerative colitis (MESH:D003093), X-linked genes (MESH:C536424), Hashimoto's thyroiditis (MESH:D050031), Klinefelter's syndrome (MESH:D007713), erosion of bone and cartilage (MESH:D002357), Lupus (MESH:D008180), asthma (MESH:D001249), SSc (MESH:D012595), toxicity (MESH:D064420), celiac disease (MESH:D002446), myocarditis (MESH:D009205), inflammatory bowel disease (MESH:D015212), autoimmune or systemic inflammatory diseases (MESH:D018746), Autoimmune Diseases (MESH:D001327), embryonic (MESH:D018236), infection (MESH:D007239), systemic autoimmune diseases (MESH:D020274), XCI (MESH:C564716), myalgia (MESH:D063806), pericarditis (MESH:D010493), autoimmune thyroid disease (MESH:D013967)
- **Chemicals:** ornithine (MESH:D009952), doxycycline (MESH:D004318), progesterone (MESH:D011374), testosterone (MESH:D013739), dihydrotestosterone (MESH:D013196), Pristane (MESH:C009042), steroid hormone (MESH:D013256), tyrosine (MESH:D014443), 17beta-estradiol (MESH:D004958), steroid sex hormones (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], H3N2 subtype (serotype) [taxon 119210], H1N1 subtype (serotype) [taxon 114727], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Mus musculus (house mouse, species) [taxon 10090], Human immunodeficiency virus (species) [taxon 12721], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Mutations:** X in T, Y264H
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829307/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829307/full.md

## References

298 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829307/full.md

---
Source: https://tomesphere.com/paper/PMC12829307